These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 9521492)

  • 1. Disruption of the actin cytoskeleton abolishes high affinity 3H-glibenclamide binding in rat aortic rings.
    Löffler-Walz C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Feb; 357(2):183-5. PubMed ID: 9521492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding and effects of KATP channel openers in the vascular smooth muscle cell line, A10.
    Russ U; Metzger F; Kickenweiz E; Hambrock A; Krippeit-Drews P; Quast U
    Br J Pharmacol; 1997 Nov; 122(6):1119-26. PubMed ID: 9401776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological characterization of the sulphonylurea receptor in rat isolated aorta.
    Löffler C; Quast U
    Br J Pharmacol; 1997 Feb; 120(3):476-80. PubMed ID: 9031752
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mg2+ and ATP dependence of K(ATP) channel modulator binding to the recombinant sulphonylurea receptor, SUR2B.
    Hambrock A; Löffler-Walz C; Kurachi Y; Quast U
    Br J Pharmacol; 1998 Oct; 125(3):577-83. PubMed ID: 9806343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between thiol-modifying agents and P1075, a K(ATP) channel opener, in rat isolated aorta.
    Linde C; Löffler C; Kessler C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Oct; 356(4):467-74. PubMed ID: 9349633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sulphonylurea binding in rat isolated glomeruli: pharmacological characterization and dependence on cell metabolism and cytoskeleton.
    Metzger F; Löffler C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):141-9. PubMed ID: 9050005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by protein kinase C of the 86Rb+ efflux and vasorelaxation induced by P1075, a K(ATP) channel opener, in rat isolated aorta.
    Linde C; Löffler C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Sep; 356(3):425-32. PubMed ID: 9303583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a specific binding site for K+ channel openers in rat aorta.
    Ouast U; Bray KM; Baumlin Y; Andres H; Manley PW
    Jpn J Pharmacol; 1992; 58 Suppl 2():226P-231P. PubMed ID: 1507537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actin cytoskeletal modulation of pressure-induced depolarization and Ca(2+) influx in cerebral arteries.
    Gokina NI; Osol G
    Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1410-20. PubMed ID: 11893578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potentiation of P1075-induced K+ channel opening by stimulation of adenylate cyclase in rat isolated aorta.
    Linde C; Quast U
    Br J Pharmacol; 1995 Jun; 115(3):515-21. PubMed ID: 7582466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of the K+ channel opener [3H]P1075 in rat isolated aorta: relationship to functional effects of openers and blockers.
    Quast U; Bray KM; Andres H; Manley PW; Baumlin Y; Dosogne J
    Mol Pharmacol; 1993 Mar; 43(3):474-81. PubMed ID: 8450836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of K(ATP) channel modulators in rat cardiac membranes.
    Löffler-Walz C; Quast U
    Br J Pharmacol; 1998 Apr; 123(7):1395-402. PubMed ID: 9579735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KCO912: a potent and selective opener of ATP-dependent potassium (K(ATP)) channels which suppresses airways hyperreactivity at doses devoid of cardiovascular effects.
    Buchheit KH; Manley PW; Quast U; Russ U; Mazzoni L; Fozard JR
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):220-30. PubMed ID: 11882918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of binding sites for [3H]P1075 and [3H]glibenclamide in renovascular hypertensive rat aorta.
    He HM; Long CL; Zhang LZ; Fu AL; Wang H
    Acta Pharmacol Sin; 2005 Jan; 26(1):69-76. PubMed ID: 15659117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The identification of a potent imidazoline-based vascular K(ATP) channel antagonist.
    Bell K; Favaloro J; Khalil V; Iskander MM; McPherson GA
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):145-51. PubMed ID: 10961377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of [3H]-P1075, an opener of ATP-sensitive K+ channels, to rat glomerular preparations.
    Metzger F; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Oct; 354(4):452-9. PubMed ID: 8897448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin stimulation of rat ventricular K+ currents depends on the integrity of the cytoskeleton.
    Shimoni Y; Ewart HS; Severson D
    J Physiol; 1999 Feb; 514 ( Pt 3)(Pt 3):735-45. PubMed ID: 9882746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a mutant sulfonylurea receptor SUR2B with high affinity for sulfonylureas and openers: differences in the coupling to Kir6.x subtypes.
    Hambrock A; Löffler-Walz C; Russ U; Lange U; Quast U
    Mol Pharmacol; 2001 Jul; 60(1):190-9. PubMed ID: 11408614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the diuretics torasemide and U-37883A with the K(ATP) channel in rat isolated aorta.
    Löffler-Walz C; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):230-7. PubMed ID: 9750009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of K(ATP) channel modulators with sulfonylurea receptor SUR2B: implication for tetramer formation and allosteric coupling of subunits.
    Löffler-Walz C; Hambrock A; Quast U
    Mol Pharmacol; 2002 Feb; 61(2):407-14. PubMed ID: 11809866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.